New York 2023-2024 Regular Session

New York Senate Bill S08694

Introduced
3/1/24  

Caption

Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.

Companion Bills

NY A00084

Same As Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.

Previously Filed As

NY S07562

Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.

NY A00084

Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.

NY A02640

Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains if such drug is in tablet or capsule form.

NY A3131

Requires labeling of over-the-counter and prescription drugs containing major food allergen or gluten-containing grain.

NY SB1094

An act to amend Section 4073.5 of the Business and Professions Code, to amend Section 1367.22 of the Health and Safety Code, and to add Section 10123.190 to the Insurance Code, relating to prescription drugs.

NY HB126

relative to prescriptions for certain controlled drugs.

NY HB126

Relative to prescriptions for certain controlled drugs.

NY HB3794

PRESCRIPTION DRUGS-VARIOUS

NY SB289

Relating to prescription drugs.

NY SB2470

Relating to the requirements for the labeling and dispensing of a prescription drug or biological product.

Similar Bills

AZ HB2291

Opioids; containers; labeling; requirements; repeal

CA AB577

Health care coverage: antisteering.

RI H8318

Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.

RI S2889

Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.

HI HB2225

Relating To Health.

HI SB2751

Relating To Workers' Compensation.

RI H5866

Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.

RI S0795

Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.